Showing results (2201-2210 of 9,628) with videos related to
Sort By:
Pageof 963
Leukemia|April 26, 2017
E-selectin ligands recognised by HECA452 induce drug resistance in myeloma, which is overcome by the E-selectin antagonist, GMI-1271A Natoni, T A G Smith, N Keane, et al.Leukemia|June 7, 2017
Long-term outcome of older patients with newly diagnosed de novo acute promyelocytic leukemia treated with ATRA plus anthracycline-based therapyD Martínez-Cuadrón, P Montesinos, E Vellenga, et al.Leukemia|June 7, 2017
Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHVmut and IgHVunmut subgroupsA Burns, R Alsolami, J Becq, et al.Leukemia|May 10, 2017
The role of LNK/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disordersN Maslah, B Cassinat, E Verger, et al.Leukemia|December 1, 1988
Transforming DNA sequences of human hepatocellular carcinomas, their distribution and relationship with hepatitis B virus sequence in human hepatomasS S Yang, R Modali, J B Parks, et al.Leukemia|December 1, 1988
Elicitation of bovine antibody to BLV-gp51 by BLV-vaccinationK Maruyama, T Fukushima, S Mochizuki, et al.Leukemia|May 12, 2017
HDAC3 regulates DNMT1 expression in multiple myeloma: therapeutic implicationsT Harada, H Ohguchi, Y Grondin, et al.Leukemia|June 6, 2017
HDAC1,2 inhibition and doxorubicin impair Mre11-dependent DNA repair and DISC to override BCR-ABL1-driven DSB repair in Philadelphia chromosome-positive B-cell precursor acute lymphoblastic leukemiaS Tharkar-Promod, D P Johnson, S E Bennett, et al.Leukemia|October 30, 2009
Targeted therapy in T-cell malignancies: dysregulation of the cellular signaling pathwaysW-L ZhaoPageof 963